相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health
Youssef A. Elnabawi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial)
Joel M. Gelfand et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)
Joel M. Gelfand et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
PR3 levels are impaired in plasma and PBMCs from Arabs with cardiovascular diseases
Abdelkrim Khadir et al.
PLOS ONE (2020)
Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1
Michael S. Garshick et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core Results From a Prospective, Observational Study
Harry Choi et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2020)
Cardiovascular Risk in Patients With Psoriasis
Michael S. Garshick et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study
Henrik Rudolf et al.
IJC HEART & VASCULATURE (2020)
Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept
Carrie Brodmerkel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Donna K. Arnett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Inflammasome Signaling and Impaired Vascular Health in Psoriasis
Michael S. Garshick et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities
Craig A. Elmets et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Identification of novel diagnostic biomarkers for deep venous thrombosis
Ashfaque A. Memon et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Increased Soluble CD137 Levels and CD4+T-Cell-Associated Expression of CD137 in Acute Atherothrombotic Stroke
Yang He et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2018)
Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment
Jaehwan Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Plasma Cystatin B Association With Abdominal Aortic Aneurysms and Need for Later Surgical Repair: A Sub-study of the VIVA Trial
Yunzhe Wang et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2018)
Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
Pei-Tzu Lin et al.
SCIENTIFIC REPORTS (2018)
A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction
Emrah Ipek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography
Marco V. Wainstein et al.
DIABETOLOGY & METABOLIC SYNDROME (2017)
Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography
Amit K. Dey et al.
JAMA CARDIOLOGY (2017)
Association of Circulating IGFBP1 Level with the Severity of Coronary Artery Lesions in Patients with Unstable Angina
Wei Zheng et al.
DISEASE MARKERS (2017)
Bone morphogenetic protein 6-a possible new player in pathophysiology of heart failure
Joanna Banach et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)
Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease
A. Safa et al.
CYTOKINE (2016)
Gene and Protein Expression of Chemokine (C-C-Motif) Ligand 19 is Upregulated in Unstable Carotid Atherosclerotic Plaques
M. K. Salem et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2016)
Comparison of Coronary Artery Calcium Scores Between Patients With Psoriasis and Type 2 Diabetes
Bobbak Mansouri et al.
JAMA DERMATOLOGY (2016)
Association Between Changes in Coronary Artery Disease Progression and Treatment With Biologic Agents for Severe Psoriasis
Kasper Fjellhaugen Hjuler et al.
JAMA DERMATOLOGY (2016)
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
Peter Willeit et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
High levels of cathepsin D and cystatin B are associated with increased risk of coronary events
Isabel Goncalves et al.
OPEN HEART (2016)
Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study
Haley B. Naik et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Serum chemokine CCL17/thymus activation and regulated chemokine is correlated with coronary artery diseases
Yicong Ye et al.
ATHEROSCLEROSIS (2015)
Left Ventricular Dysfunction and CXCR3 Ligands in Hypertension: From Animal Experiments to a Population-Based Pilot Study
Raffaele Altara et al.
PLOS ONE (2015)
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies
Jeremy Hugh et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study
Ville Jalkanen et al.
RESUSCITATION (2014)
Soluble Urokinase Plasminogen Activator Receptor A Risk Factor for Carotid Plaque, Stroke, and Coronary Artery Disease
Margaretha Persson et al.
STROKE (2014)
Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events
Danny J. Eapen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction
Tabassome Simon et al.
EUROPEAN HEART JOURNAL (2013)
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score
Stig Lyngbaek et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
David A. Martin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Serum levels of IgG4 and soluble interleukin-2 receptor in patients with coronary artery disease
Aiko Sakamoto et al.
CLINICA CHIMICA ACTA (2012)
Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events
Nehal N. Mehta et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Systemic and Vascular Inflammation in Patients With Moderate to Severe Psoriasis as Measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG-PET/CT)
Nehal N. Mehta et al.
ARCHIVES OF DERMATOLOGY (2011)
N-Terminal Pro-Brain Natriuretic Peptide and Risk of Cardiovascular Events in a Japanese Community The Hisayama Study
Yasufumi Doi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Interleukin-6, but Not Soluble Adhesion Molecules, Predicts a Subsequent Mortality from Cardiovascular Disease in Patients with Acute ST-Segment Elevation Myocardial Infarction
Zhen-Xing Fan et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2011)
Proteinase 3 and prognosis of patients with acute myocardial infarction
Leong L. Ng et al.
CLINICAL SCIENCE (2011)
Systemic chemokine levels, coronary heart disease, and ischemic stroke events The PRIME Study
F. Canoui-Poitrine et al.
NEUROLOGY (2011)
Psoriasis Therapy and Cardiovascular Risk Factors A 12-Week Follow-Up Study
Susana Coimbra et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2010)
Plasma Osteopontin as a Predictor of Coronary Artery Disease: Association With Echocardiographic Characteristics of Atherosclerosis
Hala Abdel-Hameed Abdel-Azeez et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2010)
Dynamic Cardiovascular Risk Assessment in Elderly People The Role of Repeated N-Terminal Pro-B-Type Natriuretic Peptide Testing
Christopher R. deFilippi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Myeloperoxidase and C-Reactive Protein Have Combined Utility for Long-Term Prediction of Cardiovascular Mortality After Coronary Angiography
Claire L. Heslop et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Soluble adhesion molecule E-selectin predicts cardiovascular events in Japanese patients with type 2 diabetes mellitus
Kazunari Matsumoto et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Elevated Osteopontin Levels in Patients With Peripheral Arterial Disease
Megumi Koshikawa et al.
ANGIOLOGY (2009)
Prognostic Significance of Plasma Osteopontin Levels in Patients Undergoing Percutaneous Coronary Intervention
Ryuichi Kato et al.
CIRCULATION JOURNAL (2009)
Myeloperoxidase (MPO) and Interleukin-17 (IL-17) Plasma Levels are Increased in Patients with Acute Coronary Syndromes
J. Liang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2009)
High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly
Robert C. Kaplan et al.
AMERICAN HEART JOURNAL (2008)
The association between plasma caspase-3, atherosclerosis, and vascular function in the Dallas Heart Study
Susan Matulevicius et al.
APOPTOSIS (2008)
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18
David A. Morrow et al.
EUROPEAN HEART JOURNAL (2008)
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes
G. Ndrepepa et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease
Teruo Inoue et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease
Diego Ardigo et al.
PHYSIOLOGICAL GENOMICS (2007)
Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis
Erdal Cavusoglu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Serum Myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals - The EPIC-Norfolk prospective population study
Marijn C. Meuwese et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis -: Possible pathogenic role in plaque destabilization
Jan K. Damas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Role of interleukin-17 and interieukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease
Satwat Hashmi et al.
CORONARY ARTERY DISEASE (2006)
Chemokines and incident coronary heart disease -: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002
Christian Herder et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers
D Rothenbacher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Endothelial cell markers and the risk of coronary heart disease - The Prospective Epidemiological Study of Myocardial Infarction (PRIME) study
PE Morange et al.
CIRCULATION (2004)
Plasma natriuretic peptide levels and the risk of cardiovascular events and death
TJ Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Inflammatory markers and the risk of coronary heart disease in men and women.
JK Pai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prognostic value of myeloperoxidase in patients with chest pain
M Brennan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Plasma osteopontin levels are associated with the presence and extent of coronary artery disease
R Ohmori et al.
ATHEROSCLEROSIS (2003)
Increased soluble platelet/endothelial cell adhesion molecule-1 in the early stages of acute coronary syndromes
T Soeki et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2003)
High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men
M Harrela et al.
HORMONE AND METABOLIC RESEARCH (2002)
Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study
B Wiman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure
F Pousset et al.
EUROPEAN HEART JOURNAL (2000)
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
PM Ridker et al.
CIRCULATION (2000)
分享论文
